Company: ZVRA
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001437749-25-016523
Chunk: 65

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 8
Chunk 65
---
101.INS* 
        
      Inline XBRL Instance Document 

      101.SCH* 
        
      Inline XBRL Taxonomy Extension Schema Document 

      101.CAL* 
        
      Inline XBRL Taxonomy Extension Calculation Linkbase Document 

      101.DEF* 
        
      Inline XBRL Taxonomy Extension Definition Linkbase Document 

      101.LAB* 
        
      Inline XBRL Taxonomy Extension Label Linkbase Document 

      101.PRE* 
        
      Inline XBRL Taxonomy Extension Presentation Linkbase Document 

     104**
      
     Cover page Interactive Data File (embedded within the Inline XBRL and combined in Exhibit 101)

      * 
      Filed herewith 

      ** 
      Furnished herewith 

     +
     Certain portions of the exhibit, identified by the mark, “[*]”, have been omitted because such portions contained information that is both (i) not material and (ii) the type that the Registrant treats as private or confidential.

      †
     Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule will be furnished to the Securities and Exchange Commission upon request; provided, however, that the parties may request confidential treatment pursuant to Rule 24b-2 of the Exchange Act for any document so furnished.

     40

SIGNATURES 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

      Zevra Therapeutics, Inc. 

     Date:      May 13, 2025
      By: 
      /s/ Neil F. McFarlane 

      Neil F. McFarlane 

      President and Chief Executive Officer (Principal Executive Officer) 

      Date:      May 13, 2025 
      By: 
      /s/ R. LaDuane Clifton 

      R. LaDuane Clifton, MBA, CPA 

      Chief Financial Officer and Treasurer (Principal Financial Officer) 

       41